Protection against Oxidative Damage by Iron Chelators: Effect of Lipophilic Analogues and Prodrugs of N,N‘-Bis(3,4,5-trimethoxybenzyl)ethylenediamine- N,N‘-diacetic Acid (OR10141)
- 16 March 2000
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 43 (7), 1418-1421
- https://doi.org/10.1021/jm9911635
Abstract
N,N‘-Bis(3,4,5-trimethoxybenzyl)ethylenediamine-N,N‘-diacetic acid (1) was recently described as a new type of iron chelator for protection against oxidative damage. It has a low affinity for iron, but the corresponding iron complex undergoes a site-specific oxidation by hydrogen peroxide through intramolecular aromatic hydroxylation into a highly stable iron phenolato complex, which does not catalyze hydroxyl radical formation. The purpose of this local activation process is to minimize toxicity compared to strong iron chelators, which may interfere with normal iron metabolism. 1 efficiently protects biological molecules against oxidative damage in vitro but not intact cells because of poor membrane permeability. We show here that, among a series of prodrug esters and lipophilic analogues, membrane-permeant N,N‘-bis(3,4,5-trimethoxybenzyl)ethylenediamine-N,N‘-diacetic acid diacetoxymethyl ester (7) protects human skin fibroblasts against hydrogen peroxide toxicity with an IC50 of 3 μM. These results thus demonstrate that, providing sufficient intracellular chelator concentration is reached, 1 efficiently protects cells against the deleterious effects of hydrogen peroxide. This strategy of oxidative activation should help the design of new chelators with better safety margins, which may be useful against oxidative damage under conditions where a prolonged administration is needed.Keywords
This publication has 9 references indexed in Scilit:
- Ultraviolet A radiation induces immediate release of iron in human primary skin fibroblasts: The role of ferritinProceedings of the National Academy of Sciences of the United States of America, 1999
- O2 Activation and Aromatic Hydroxylation Performed by Diiron ComplexesJournal of the American Chemical Society, 1998
- The Potential Role of Iron Chelators in the Treatment of Parkinson's Disease and Related Neurological DisordersBasic & Clinical Pharmacology & Toxicology, 1997
- Aromatic Hydroxylation by H2O2 and O2 Catalyzed by a μ‐Oxo Diiron(III) ComplexAngewandte Chemie-International Edition, 1996
- Synthetic and Structure/Activity Studies on Acid-Substituted 2-Arylphenols: Discovery of 2-[2-Propyl-3-[3-[2-ethyl-4-(4-fluorophenyl)-5-hydroxyphenoxy]- propoxy]phenoxy]benzoic Acid, a High-Affinity Leukotriene B4 Receptor AntagonistJournal of Medicinal Chemistry, 1995
- Iron-Chelating Agents in Non-Iron Overload ConditionsAnnals of Internal Medicine, 1994
- Iron-mediated DNA damage: Sensitive detection of DNA strand breakage catalyzed by ironJournal of Inorganic Biochemistry, 1992
- Spin probes as mechanistic inhibitors and active site probes of thymidylate synthetaseJournal of Medicinal Chemistry, 1986
- Calcium homeostasis in intact lymphocytes: cytoplasmic free calcium monitored with a new, intracellularly trapped fluorescent indicator.The Journal of cell biology, 1982